---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-024708"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T20:00:17.131215+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Kintara Therapeutics effects 1-for-50 reverse stock split, trading on adjusted basis Nov 14

## Summary
- Reverse stock split at 1:50 ratio effective 5:00 p.m. ET on November 11, 2022.
- No fractional shares issued; any fractional shares rounded up to nearest whole share.
- Common stock continues trading on Nasdaq under ticker KTRA, new CUSIP 49720K200.
- Authorized shares of common stock reduced proportionally from 50 to 1.
- Board approved the split on October 28, 2022; no stockholder vote required under Nevada law.

## SEC filing metadata
- accession: 0000950170-22-024708
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000095017022024708/0000950170-22-024708-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000095017022024708/ktra-20221110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-024708
- JSON: https://secwatch.observer/filing/0000950170-22-024708.json
- Plain text: https://secwatch.observer/filing/0000950170-22-024708.txt

## Key facts
- Governance Changes
  TuHURA Biosciences, Inc./NV: Effected a one-for-fifty (1:50) reverse stock split of common stock and corresponding reduction in authorized shares via Certificate of Change to Articles of Incorporation (effective 2022-11-11).
  - Change: charter amendment
  - Effective: 2022-11-11
  source text: On November 10, 2022, Kintara Therapeutics, Inc. (the “Company”) filed a Certificate of Change to the Company’s Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada (the “Certificate of Change”), which effected, at 5:00 p.m. Eastern Time on November 11, 2022, a one-for-fifty (1:50) reverse stock split (the “Reverse Stock Split”) of both the Company’s issued and outstanding shares of common stock, $0.001 par value per share (the “Common Stock”) and authorized shares of Common Stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000095017022024708/0000950170-22-024708-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.